Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Mar 9, 2010


Fluidigm has released 5-kilobase and 10-kilobase long-range PCR protocols for its Access Array system, allowing users to amplify up to 48 samples per array for use in targeted resequencing.

Fluidigm said that the new protocols allow users to enrich up to 240 kb per sample and 11.5 megabases per array, or 480 kb and 23 Mb per array, respectively, from 48 samples at a time.

The Access Array system uses as little as two microliters of PCR master mix per 48 amplicons, and the entire sample-prep workflow requires three pipette steps per 48 amplicons, according to the company. This enables the enrichment of up to 23 Mb per array in as little as four hours and for less than $7 per sample, Fluidigm said.

Access Array is compatible with several next-generation sequencing platforms, including the Roche 454 FLX, Illumina Genome Analyzer II, and Life Technologies SOLiD 4.

Epigentek has launched its BisulFlash DNA Modification Kit, which can convert unmethylated cytosine into uracil in around 30 minutes, the company said.

The converted DNA eluate can be obtained for use in mutagenically separated PCR, real-time MS-PCR, methylation microarray, and methylation sequencing and pyrosequencing applications, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.